Clinical Trial Update: Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gentamicin-induced readthrough in cystic fibrosis patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Gentamicin (gentamicin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED